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ABSTRA CT
The promoter activity of the rat Ca
2+/calmodulin-dependent
protein kinase II gene was analyzed using the luciferase
reporter gene in neuronal and non-neuronal cell lines. Neuronal
cell type-specific promoter activity was found in the 5’-
flanking region of a and b isoform genes of the kinase.
Silencer elements were also found further upstream of
promoter regions. A brain-specific protein bound to the DNA
sequence of the 5’-flanking region of the gene was found by
gel mobility shift analysis in the nuclear extract of the rat brain,
including the cerebellum, forebrain, and brainstem, but not in
that of non-neuronal tissues, including liver, kidney and spleen.
The luciferase expression system and gel shift analysis can be
used as an additional and better index by which to monitor
gene expression in most cell types.
INTRODUCTION
Ca
2+/calmodulin-dependent protein kinase II (CaM kinase II) is
one of the most abundant protein kinases in mammalian brain
and a major mediator of calcium signaling in neurons. CaM
kinase II is involved in diverse functions in neurons, including
neurotransmitter synthesis and neurotransmitter release,
modulation of ion channel activity, synaptic plasticity, learning
and memory, and gene expression (1-7). The a and b isoforms
of CaM kinase II are expressed almost exclusively in the
nervous system, but the expression of both isoforms is not
uniform throughout the brain, and is regulated
developmentally. In the adult rat, the a isoform is abundant in
the forebrain, whereas the b isoform is abundant in the
cerebellum (8,9). The enzyme level is increased most rapidly in
postnatal brain during the most active phase of synapse
formation (10-12). Thus, the space-temporal gene expression
of CaM kinase II indicates that the enzyme is carefully
regulated at the level of transcription. The transcriptional
regulation of many eukaryotic genes has been extensively
studied and tissue-specific enhancer and silencer elements have
been identified. However, little is known about the neuronal
cell type-specific expression of the CaM kinase II gene.
Therefore, it is imperative that there is a method to analyze the
gene expression. We have analyzed the promoter activity and a
protein bound to the DNA sequence of the gene (13,14). Some
of our procedures may be modified, although major procedures
are known to provide good results.
MATERIALS AND METHODS
Materials
[g-
32P]ATP (specific activity of 110 TBq/mmol) was purchased
from NEN
TM Life Science Products, Inc. (Boston, MA.).
Double strand poly(dI-dC) and Sephadex G-50 were obtained
from Amersham Pharmacia Japan (Tokyo, Japan).
Oligonucleotide primers were synthesized by Biologica Co.
(Nagoya, Japan), or by Invitrogen Life Tech. Japan (Tokyo,
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Japan). Luciferase assay system, luciferase reporter pGL2- and
pGL3-control  vectors,  pGL2-  and  pGL3-basic  vectors,  and
Wizard
TM Plus Minipreps DNA purification system were from
Promega Corp. (Madison, WI). Geneclean II DNA purification
kit  was  from  BIO  101  Inc.  (Vista,  CA).  FuGENE
TM6
transfection  reagent  and  chlorophenol  red  b-D-
galactopyranoside (CPRG) were from Roche Diagnostics Japan
Corp.  (Tokyo,  Japan).  Dulbecco’s  modified  Eagle’s  medium
(DMEM),  Ham  F12  medium,  and  DMEM/Ham  F12  (1:1)
medium  were  from  Invitrogen  Life  Tech.  Japan  (Tokyo,
Japan). Eagle’s MEM amino acids and vitamins medium was
from  Nissui  Pharmaceutical  Co.  Ltd.  (Tokyo,  Japan).  Fetal
bovine serum (FBS) was from JRH Bioscience (Lenexa, KS).
X-OMAT film was from Eastman Kodak Company (Rochester,
NY).
Construction of a a a a and b b b b CaM Kinase II
Promoter-Luciferase Reporters
a CaM kinase II promoter-luciferase reporters were created by
polymerase chain reaction (PCR) with cloned genomic DNA
(CL-1 clone) (15) as a template. PCR fragments possessing 5’
flanking  sequences  with  various  5’  sense  primers  and  a
common  3’  end  at  +112  were  inserted  into  a  promoterless
pGL3-basic vector. The 5’ sense and 3’ antisense primers were
designed according to the sequence of the gene as shown in
Table  1  (see  Protocols  section).  To  the  5’  sense  and  3’
antisense  primers  were  added  BglII  and  HindIII  restriction
sites, respectively. PCR products were separated by agarose gel
electrophoresis  and  excised,  and  then  purified  using  the
Geneclean  II  kit.  PCR  products  were  also  separated  by
polyacrylamide gel electrophoresis (PAGE) and  excised, and
then  purified  as described  (16).  Purified  PCR  products  were
digested with BglII and HindIII, and ligated into a promoterless
pGL3-basic  vector. The  5’  flanking  sequence  containing  8.5
kbp of the mouse a CaM kinase II gene (17) was digested with
SalI and inserted into pGL3-basic vector to make pGLma8.5k.
 b CaM kinase II promoter-luciferase reporters were prepared
in the same way as the a CaM kinase II luciferase reporters.
Genomic DNA clone (BCL-1) or the subcloned plasmid DNA
of the b CaM kinase II gene (14) was used as a template. To
the  5’  sense  and 3’ antisense  primers  were added  KpnI  and
XhoI restriction sites, respectively. PCR fragments were cloned
directly  into  a  promoterless  pGL2-basic  vector.  A  construct
devoid  of  the  transcription  initiation  site  (pGLD0.57)  was
prepared from the fragment of NcoI (nucleotide -577) and EheI
(nucleotide -45) of the gene.
Cell Culture and Transfection
The following cell lines were used in the experiment; neuronal
NG108-15,  N18TG2,  and  CAD  cells  and  non-neuronal
BALB/c3T3,  CHO-K1,  and  HT1080  cells.  For  transient
transfection, cultured cells were plated on 35-mm tissue culture
dishes at approximately 1-3 x 10
5 cells/dish, and cultured 24 h.
Luciferase reporter DNA (1.2 µg  of  pGL2-  or  pGL3-control
vector or the molar equivalent of luciferase constructs) with b-
galactosidase expression vector (pcDNA3/b-gal) DNA (0.8 µg)
were  introduced  into  the  cells  via  FuGENE
TM6  reagent
treatment (3 µl of FuGENE
TM6 reagent/dish) as instructed by
the  manufacturer.  After  24  h,  cells  were  harvested  and
extracted  for  assay.  All  transfections  were  performed  in
duplicate.
Luciferase Expression
Plated  cells  were  washed  with  phosphate-buffered  saline
(PBS),  and  then  lysed  in  200  µl  of  lysis  buffer.  Luciferase
activity was assayed in a reaction mixture containing 20 mM
tricine,  pH  7.8,  470  µM  luciferin,  530  µM  ATP,  270  µM
Coenzyme  A,  1.07  mM  (MgCO3)4Mg(OH)2•5H20,  2.67
mM MgSO4,  0.1  mM  EDTA,  33.3  mM  dithiothreitol,  and
nuclear extract. Luciferase activity was measured for 20 s after
the  addition  of  reagents.  The  efficiency  of  transfection  was
corrected by the b-galactosidase activity. Promoter activity was
compared by measuring the luciferase activity of the pGL2- or
pGL3-control vector with the SV40 early gene promoter, and
expressed  as  normalized  luciferase  activity.  b-Galactosidase
activity was assayed by a modification of the method described
by  Herbmel  et  al.  (18) The  enzymatic activity  of  individual
samples was measured in triplicate.
Electrophoretic Mobility Shift Analysis
Nuclear extracts were prepared as described  (19).  Sense and
antisense  oligonucleotide  probes  were  annealed,  and  end-
labeled  with  [g-
32P]ATP  and  T4  polynucleotide  kinase.  The
binding  reaction  was  carried  out  in  a  reaction  mixture
containing 25 mM Tris buffer (pH 7.5), 75 mM KCl, 1 mM
EGTA,  1  µg  of  poly(dI-dC),  13%  glycerol,  10  µg  of  the
nuclear  extract,  and  20-50  fmol 
32P-labeled  probe  (about
10,000 cpm) with or without non-labeled probe or competitor
DNA. After incubation for 30 min at 0 °C, the reaction mixture
was separated by 6.4% polyacrylamide gel electrophoresis at
200  V  for  30  min  in  0.5x  TBE,  fixed,  dried,  and
autoradiographed.
RESULTS AND DISCUSSION
Analysis of Promoter Activity of a a a a CaM Kinase
II Gene
We  examined  the  promoter  activity  in  neuronal  and  non-
neuronal cell lines. Transient transfection was used to compare
the  promoter  activity  of  the  luciferase  reporter  gene.  The
structure of the 5’-flanking region of the a CaM kinase II gene
and one of the luciferase reporters  (pGLa2281)  is  shown in
Fig.  1A.  Fragments  possessing  a  common  3’  end  (+112  bp)
containing a sequence of 2281, 1622, 757, 275, 199, 145, and
100 bp 5’ upstream from the transcription initiation site wereMima et al. 81
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cloned  upstream  of  the  luciferase  reporter  gene  in  a
promoterless  pGL3-basic  vector  to  make  respective  pGLa
constructs. a CaM kinase II promoter activity was compared
with  that  of  pGL3-control  vector  by  measuring  luciferase
activity, and expressed as normalized luciferase activity.
Relative Luciferase Activity
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Fig. 1: Promoter-luciferase reporter and deletion analysis of CaM kinase II promoter activity in transiently transfected
neuronal and non-neuronal cells. A. A schematic representation of the 5’ flanking region of the a CaM kinase II gene (Upper)
and one of the a CaM kinase II promoter-luciferase reporters (Lower). a CaM kinase II promoter-luciferase reporters were created
by PCR amplification using the 5’ flanking sequence of the gene. The sequence is numbered with respect to the transcription
initiation site (indicated as +1) shown by an arrow. The box represents exon 1 and the translation initiation site is shown by ATG
and +150. Black box shows neuronal cell type-specific promoter region found in this study. Restriction enzyme sites and their
positions are shown; B, BamHI; Bg, BglII; H, HindIII; N, NcoI; P, PstI. B and C. Deletion analysis of a CaM kinase II promoter
activity in transiently transfected neuronal and non-neuronal cells. Luciferase reporters were co-transfected with the internal control
of  pcDNA3/b-gal  into  neuronal  cells,  NG108-15  (B),  and  into  non-neuronal  cells,  BALB/c3T3  (C).  Luciferase  activity  was
measured 24 hr later, and is expressed relative to that obtained with the control vector after correcting for the transfection efficiency
based on co-transfection with pcDNA3/b-gal. The activity observed with pGL3-control vector was used as a positive control and
expressed  as  1.00.  All  values  are  presented  as  the  mean  of  three  assays.  The  data  are  representative  of  three  independent
experiments. D. A schematic representation of the 5’ flanking region of the b CaM kinase II gene (Upper) and one of the b CaM
kinase II promoter-luciferase reporters (Lower). b CaM kinase II promoter-luciferase reporters were created by PCR. The sequence
is numbered as in A. Black box shows neuronal cell type-specific promoter region found in this study. Restriction enzyme sites and
their positions are shown; B, BamHI; Eh, EheI; Nc, NcoI; Nh, NheI; S, Sac I. E and F. Deletion analysis of b CaM kinase II
promoter activity in transiently transfected cells. Luciferase reporters were co-transfected with the internal control of pcDNA3/b-
gal to neuronal cells, NG108-15 (E), and non-neuronal cells, BALB/c3T3 (F). Activity observed with pGL2-control vector was
used as a positive control and expressed as 1.00. Luciferase activity was measured after 24 h. Data are representative of three
experiments and similar results were obtained.Mima et al. 82
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In  NG108-15  cells,  the  strongest  promoter  activity  was
obtained with pGLa199, which yielded a 3.68-fold increase in
luciferase  activity  relative  to  pGL3-control  vector  (Fig.  1B).
pGLa145 also showed high promoter activity at about 40% of
that of pGLa199, but pGLa100 showed very little  promoter
activity. An internal deletion mutant (pGLa199D) that had no
transcription  initiation  site  showed  no  significant  promoter
activity  in  NG108-15  cells,  indicating  that  the  transcription
initiation site was important to the transcription of the a CaM
kinase II gene. Similar results were obtained in neuronal cell
lines,  N18TG2  and  CAD  (data  not  shown),  and  normalized
luciferase  activity  of  pGLa199  in  NG108-15,  N18TG2,  and
CAD  cells  was  3.68,  3.08, and  1.87, respectively.  However,
luciferase activity was extremely weak in non-neuronal cells -
about 0.007 in BALB/c3T3 (Fig. 1C). In other non-neuronal
cell lines, HT1080, and CHO-K1, the activity was also low and
less  than  0.05  (data  not  shown).  Promoter  activity  in  non-
neuronal cells was 100- to 500-fold lower than that in neuronal
cells. These results indicated that the 5’ upstream region -199
to  -100  bases  from  the  transcription  initiation  site  showed
neuronal cell type-specific strong promoter activity.
The  inclusion  of  an  additional  5’  flanking  sequence  of  275
bases  (pGLa275)  decreased  luciferase  expression  only  0.57-
fold  relative  to  the  pGL3-control  vector  in  NG108-15  cells
(Fig. 1B). The luciferase activity of pGLa275 was almost the
same as that of pGLa757, pGLa1662, and pGLa2281. Since
the  sequence  of  the  8.5  kbp  5’  flanking region  is  known  to
show brain-specific expression of a CaM kinase II (17),  the
promoter activity of pGLma8.5k was compared  with  that  of
the rat promoter. pGLma8.5k showed weak promoter activity,
as  did  pGLa275  in  NG108-15  cells.  Similar  results  were
obtained in N18TG2 and CAD cells (data not shown). These
results indicate that there is a strong silencer element within the
5’  upstream  region  -275  to  -199  bp  from  the  transcription
initiation site.
The promoter activity of all regions of the 5’-flanking sequence
was much weaker in non-neuronal cells including BALB/c3T3,
HT1080 and CHO-K1 than in neuronal cells (Fig. 1C, and data
not shown).
Analysis of Promoter Activity of b b b b CaM kinase II
Gene
Since the b isoform was expressed almost exclusively in the
brain, the promoter activity of the b CaM kinase II gene was
also examined. The structure of the 5’ flanking region of the b
CaM  kinase  II  gene  and  one  of  the  luciferase-reporters
(pGL3.2)  is  shown  in  Fig.  1D.  Fragments  possessing  a
common 3’ end (+78 bp) containing  sequences  of  3.2,  0.57,
0.32,  0.22,  0.12,  0.06,  and  0.03  kbp  5’  upstream  from  the
transcription  initiation  site  were  cloned  upstream  of  the
luciferase reporter gene in a promoterless pGL2-basic vector to
make  respective  pGL  constructs.  The  luciferase  activity  of
these  reporters  was  analyzed  in  neuronal  cells,  NG108-15,
N18TG2,  and  CAD  cells,  and  in  non-neuronal  cells,
BALB/c3T3, HT1080, and CHO-K1 cells. The results indicate
that the 5’ upstream region -66 to -35 bp from the transcription
initiation  site  contained  neuronal  cell  type  specific  strong
promoter  activity,  and  that  there  are  two  silencing  elements
within  the  regions  -222  to  -123  bp  and  -576  to  -323  bp.
Representative results are shown in Fig. 1E and 1F.
The relative luciferase activity of the a isoform gene was lower
than that of the b isoform, because the luciferase activity of the
pGL3-control vector was about 5 to 10-fold that of the pGL2-
control vector. pGL3-control vector contains more SV40 early
gene promoter than pGL2-control vector as described by the
manufacturer.
Investigation of Nuclear Protein Bound to DNA
of the Promoter Region of b b b b CaM kinase II
Since neuronal cell type-specific promoter activity was found
in the region from -66 to -35 bp of the b CaM kinase II gene, a
gel mobility shift analysis was performed using nuclear extract
from various rat tissues. The 32P-labeled probe was incubated
with  nuclear  extract  of  the  brain,  including  forebrain,
cerebellum, and brainstem, and non-neuronal tissues, including
liver,  kidney  and  spleen.  A  band  specific  to  the  brain  was
observed as indicated by an arrow in Fig. 2A, although some
other  bands  were  expressed  ubiquitously.  Its  density  was
highest in the cerebellum, consistent with the expression of b
CaM kinase II (8,9).
The radioactivity  of  this  band  detected  by  incubation  of  the
extract  of  cerebellum  was  reduced  almost  completely  in  the
presence of a 5-fold excess of non-radioactive probe (Fig. 2B).
These results indicate that  this  band  was  formed  by  specific
binding of the nuclear protein in the brain.
A protein bound to the promoter regions (nucleotides -145 to -
100, and -199 to -146) of a CaM kinase II was also found in
the nuclear extract of rat brain, including forebrain, brainstem
and  cerebellum,  but  not  in  non-neuronal  tissues,  including
liver,  kidney  and  spleen  (data  not  shown).  There  is  no
homology in the sequence in the promoter region of both a and
b genes. The sequence of the promoter region is 5’- CTT CTG
GGC  CCA CAC AGT CCT GCA GTA TTG TGT ATA TAA
GGC  CAG  GGC  AAC  GGA  GGA  GCA  GGT  TTT  GAA
GTG AAA GGC AGG CAG GTG TTG GGG AGG CAG T -
3’ (-199 to -100) for the a gene and 5’- CAG CCA GCC CGG
CCC CCG CCC GGC GCC GCG AG -3’ (-66 to -35) for the b
gene. Known transcription factor binding sites were underlined
which corresponded to TATA box, v-myb, and MyoD in the a
gene and Sp1 in the b gene, respectively. These sites were not
specific to neuronal cells. Thus, it is suggested that there are
unidentified promoter elements in these regions.Mima et al. 83
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Fig. 2: Gel mobility shift analysis using the -66 to -35 region
of b b b b CaM kinase II. Ten µg of nuclear extract and 0.2 ng of
32P-labeled  probe  (about  1  x  10
4  cpm)  were  used  in  the
experiments.  A,  tissue  specificity  of  DNA  binding  protein,
Lanes  1  -  6,  nuclear  extract  from  forebrain,  cerebellum,
brainstem,  liver,  kidney  and  spleen  of  rat,  respectively.  B,
specificity  of  probe.  Nuclear  extract  of  cerebellum  was
incubated  with 
32P-labeled  probe  in  the  presence  of  non-
radioactive  probe  or  competitor  DNA.  Lane  1,  without  non-
radioactive probe; lanes 2 - 4, in the presence of a 1-, 2.5-, and
5-fold mole excess of non-radioactive probe, respectively; lane
5, in  the  presence  of  a  5-fold  mole  excess  of  the  scrambled
sequence.
Conclusion
We have established a method for luciferase reporter analysis
by which the number of cells expressing a specific gene can be
monitored through the assay of luciferase and b-galactosidase
activities. The method provides an alternative for analyzing the
promoter activity of different genes. The main observations we
have  made  with  this  technique  are  1)  neuronal  cell  type-
specific expression of the a and b gene occurs in neuronal cell
lines  (silencer  elements  were  also  found in  further  upstream
promoter regions) and 2) neuronal cell type-specific proteins
bound to the promoter region are found in nuclear extracts of
brain cells.
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PROTOCOLS
Construction and purification of a a a a and b b b b CaM Kinase II Promoter-Luciferase Reporter
a and b CaM kinase II promoter-luciferase reporters were created by PCR with genomic DNA as a template.
1. PCR primers of a CaM kinase II are shown in Table 1. To the 5’ sense and 3’ antisense primers were added 2 base plus BglII
(5’-GAAGATCT-3’) and HindIII (5’-CCAAGCTT-3’) restriction sites, respectively.
2. PCR primers of b CaM kinase II are shown in Table 1. To the 5’ sense and 3’ antisense primers were added 2 base plus KpnI
(5’-GGGGTACC-3’) and XhoI (5’-CCCTCGAG-3’) restriction sites, respectively.
3. The PCR reaction mixture contains the following in a final volume of 25 µl:
· 20 mM Tris/HCl, pH 8.8, 2 mM dNTP,10 mM KCl, 2 mM MgCl2, 10 mM (NH4)2SO4, 0.1% Triton X-100, 1 unit of pfu
DNA polymerase, 0.4 µM 5’ sense- and 0.4 µM 3’ antisense-oligonucleotide primers, and 100 pg of genomic DNA clone
containing the 5’ flanking region of a or b CaM kinase II
4. The amplification profile involved initial denaturation at 94 °C for 2 min, then denaturation at 98 °C for 20 s, annealing at 56
°C for 1 min, and extension at 72°C for 1 min except for the extension of pGLa2281, pGLa1162, and pGL3.2 (3 min). The
reaction was repeated for 30 cycles. An automated DNA thermal cycler was used.
5. Separate the PCR products by agarose gel or polyacrylamide gel electrophoresis.
6. Detect the DNA with ethidium bromide under a UV lamp, and cut out the segment of the gel containing the band of interest.
7. Extract and purify the DNA from the gel as described below.
8. Digest the PCR product of the a CaM kinase II gene with 1 unit each of BglII and HindIII or that of the b CaM kinase II gene
with 1 unit each of KpnI and XhoI for 1 hr at 37 °C.
9. Heat the reaction mixture at 70 °C for 5 min to inactivate the restriction enzymes.
10. Withdraw a 1 µl aliquot and add to 20 µl of ligation reaction mixture.
11. Add 20 ng of appropriately digested pGL3- and pGL2-basic vectors and 1 unit of T4 ligase to the mixture, and incubate for 1
hr at 16 °C.
12. Transform the ligation product to E. coli DH5a.
13. Purify the luciferase reporter plasmid using the Wizard
TM Plus Minipreps DNA purification system.
14. Check the purity of the reporter plasmid DNA by 1% agarose gel electrophoresis. The yield of purified reporter plasmid DNA
was usually 50-100 µg from 10 ml of culture of E. coli. under these conditions.
Purification of PCR Product by Agarose Gel Electrophoresis
The PCR product was purified from agarose gel using Geneclean II DNA purification kit according to the manufacturer’s
instructions.
1. Prepare the following solutions:
· TAE: 40 mM Tris-acetate, pH 8.0, and 1 mM EDTA
· TE7.5: 10 mM Tris/HCl, pH 7.5, and 1 mM EDTA
2. Separate the PCR products by 1% agarose gel electrophoresis in TAE at 100 V for 30 min. Cut out the segment of the gel
containing the band of interest.
3. Transfer the gel slice (about 100 µg) to a 1.5-ml microfuge tube. Add 3 volumes of NaI solution to the agarose gel. Heat at 50
°C for 5 min to dissolve the agarose gel, then cool at 0 °C.
4. Add 3 µl of glassmilk to the solution, mix well, and centrifuge for 5 s at 15,000 rpm. Remove the supernatant.
5. Wash the precipitate with 500 µl of new wash solution. Centrifuge for 5 s at 15,000 rpm. Remove the supernatant. Repeat
these steps twice.
6. Add 10 µl of 0.1x TE7.5 to the precipitate and mix well. Centrifuge at 15,000 x for 40 s. Transfer the supernatant to a new
tube and obtain the purified PCR product.Mima et al. 86
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Table 1: Oligonucleotide primer sequences used for PCR
Construct 5' Sense primer (nucleotide number) 3' Antisense primer (nucleotide number)
a Gene
pGLa2281 5'-CTTAGAGCAGTGGTTCTCAA-3' (-2281 to -2262) 5'-GACTAGGACTGGGATGCTGA-3' (+93  TO +112)
PGLa1622 5'-CTTGAGCCTCAGTTGGGTC-3' (-1622 to -1604)
pGLa757 5'-CTTCAGAGTTCTGGGTTTGC-3' (-757 to -738)
pGLa275 5'-CTTGTGGACTAAGTTTGTTCA-3' (-275 to -255)
pGLa199 5'-CTTCTGGGCCCACACAGTC-3' (-199 to -181)
pGLa145 5'-GGAGCAGGTTTTGAAGTGAAA-3' (-145 to -125)
pGLa100 5'-TTACCGGGGCAACGGGAAC-3' (100 to -82)
pGLa199d 5'-CTTCTGGGCCCACACAGTC-3' (-199 to -181)
b Gene
pGL3.2 5'-CTCCTGGCGGGGACAGAG-3' (PUC vector sequence) 5'-GGCGGTGGCGATTGGGCTC-3' (+60 to +78)
pGL0.57 5'-CTCCTGGCGGGGACAGAG-3' (PUC vector sequence)
pGL0.32 5'-CGACATGTGTGCGAAGGGAG-3' (-320 to -301)
pGL0.22 5'-CGAGTGTAGGGTGCGAGAGAG-3' (-218 to 198)
pGL0.12 5'-CTCCTGGCGGGGACAGAG-3' (-116 to -99)
pGL0.06 5'-CAGCCAGCCCGGCCCC-3' (-66 to -51)
pGL0.03 5'-CCGAGGTGTCTCCCGCG-3' (-34 to -18)
Table 1: Oligonucleotide sequences were derived as previously described (13, 14).
Purification of PCR Product by Polyacrylamide Gel Electrophoresis
 The PCR product was purified from polyacrylamide as previously described (16).
1. Prepare the following solutions:
· TBE: 9 mM Tris-borate, pH 8.0, and 2 mM EDTA.
· Elution buffer: 0.5 M CH3COONH4, 10 mM Mg(CH3C00)2, 1 mM EDTA, and 0.1% SDS
2. Separate the PCR products by 5.6% polyacrylamide gel electrophoresis in TBE at 75 V for 1 hr.
3. Transfer the gel slice (about 100 µg) to a 1.5-ml microfuge tube. Add 2 volumes of elution buffer and crush the gel with the
plastic tip.
4. Incubate the mixture at 37 °C for 4 hr with shaking. Centrifuge at 12,000 rpm for 1 min, then transfer the supernatant to a new
tube.
5. Add 2 volumes of ethanol. Let stand for 30 min at 4 °C. Centrifuge at 15,000 rpm for 15 min at 4 °C. Remove the supernatant.
6. Dissolve the precipitate in 100 µl of TE7.5.
7. Add 8 µl of 5 M NaCl and 250 µl of ethanol to the solution and mix well. Stand for 30 min at 4 °C and then centrifuge at
15,000 rpm for 15 min at 4 °C. Remove the supernatant and dry the precipitate under reduced pressure.
8. Dissolve the purified PCR product in 10 µl of TE7.5.
Transformation and Purification of Luciferase Reporter Plasmid DNA
Luciferase reporter plasmid DNA was purified using the Wizard
TM Plus Minipreps DNA purification system according to the
manufacturer’s instructions with some modifications.
The solution contains the following:
· SOC medium: 2% trypton, 0.5% yeast extract, 8.6 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, and 20 mM glucose (adjust
the pH to 7.0 with 5 N NaOH)
· LB (Luria-Bertani)-ampicillin medium: 1% trypton, 0.5% yeast extract, 1% NaCl, and 50 µg/ml ampicillin (adjust the pH
to 7.0 with 5 N NaOH)Mima et al. 87
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· TB (Terrific Broth)-ampicillin medium: 17 mM KH2PO4, 72 mM K2HPO4, 1.2% trypton, 2.4% yeast extract, 0.4%
glycerol, and 50 µg/ml ampicillin
· Cell resuspension solution: 50 mM Tris/HCl, pH 7.5, 10 mM EDTA, and 100 µg/ml RNase A
· Cell lysis solution: 0.2 N NaOH, and 1% SDS
· Neutralization solution: 1.32 M K-acetate, pH 4.8
· Column wash solution: 20 mM Tris/HCl, pH 7.5, 200 mM NaCl, 5 mM EDTA, and 55% ethanol
1. Transfer 4 µl of the ligation mixture into 96 µl of E. coli DH5a competent cell suspension. Incubate successively at 0 °C for 1
hr at 42 °C for 45 s, and then at 0 °C for 2 min.
2. Add 900 µl of SOC medium. Incubate at 37 °C for 1 hr with shaking.
3. Withdraw a 200-µl aliquot of E. coli suspension, and plate onto LB-ampicillin. Incubate at 37 °C for 15 hr.
4. Remove a single colony and culture in 10 ml of TB-ampicillin medium at 37 °C for 15 hr.
5. Harvest cells by centrifugation at 5,500 rpm for 5 min.
6. Completely resuspend the cell pellet in 1 ml of cell resuspension solution.
7. Add 1 ml of cell lysis solution and mix by inverting the tube 4 times. The cell suspension should clear up immediately.
8. Add 0.5 ml of 2x neutralization solution and mix by inverting the tube 4 times.
9. Centrifuge the lysate at 17,000 rpm for 15 min at 4 °C. Transfer the supernatant to a 15-ml plastic tube.
10. Add 4 ml of 7 M guanidine/HCl and 2 ml of resuspended DNA purification resin into the cleared lysate. Mix by inverting the
tube for 5 min.
11. Transfer the mixture to a 10-ml syringe attached to a minicolumn. Carefully insert the syringe plunger and gently push out the
slurry into the column.
12. Wash the column with 5 ml of column wash solution.
13. Remove the syringe and transfer the minicolumn to a 1.5-ml microfuge tube. Centrifuge the column at 10,000 rpm for 20 s to
dry the resin.
14. Transfer the minicolumn to a new 1.5-ml microfuge tube. Apply 50 µl of TE7.5 prewarmed at 65-70 °C and wait 1 min.
Centrifuge at 10,000 rpm for 20 s to elute DNA. Remove the minicolumn. Store the purified plasmid DNA in the microfuge
tube at -20 °C.
Transfection of Luciferase Reporter and Preparation of Cell Extract
The culture medium for each cell line is the following. Note that all culture media contained 0.007% penicillin and 0.01%
streptomycin:
· Mouse neuroblastoma-rat glioma hybridoma NG108-15 cells; DMEM supplemented with 10% FBS and 0.1 mM
hypoxanthine, 1 mM aminopterin and 16 mM thymidine (HAT)
· Mouse neuroblastoma N18TG2 cells; DMEM supplemented with 10% FBS
· Mouse central nervous cell line CAD cells; DMEM/F12 medium supplemented with 8% FBS
· Mouse fibroblast BALB/c3T3 cells; DMEM supplemented with 10% FBS
· Human fibroblast HT1080 cells; DMEM supplemented with 10% FBS
· Chinese hamster ovary CHO-K1 cells; Ham F12 medium supplemented with 10% FBS
The lysis buffer contains the following:
· 25 mM Tris buffer, pH 7.8, 2 mM EDTA, 2 mM dithiothreitol, 10% glycerol, and 1% Triton X-100
Ca
2+/ Mg
2+-free-DMEM is prepared as follows:
· Dissolve the following reagents in a total volume of 200 ml of water; 176 mg of Eagle’s MEM amino acids and vitamins
medium, 50 mg of KCl, 1280 mg of NaCl, 25 mg of NaH2PO4•12H2O, 200 mg of D-glucose, 22 mg of sodium pyruvate,
6 mg of glycine, 8.4 mg of L-serine, and 440 mg of NaHCO3. Add 14 mg of penicillin and 20 mg of streptomycine.
Introduce CO2 gas, and sterilize by passage through a 0.22-µm filter
1. Seed cells at approximately 1-3 x 10
5 /35 mm dish in 1 ml of culture medium, and culture at 37 °C in a 7 % CO2 humidified
incubator for 24 hr.
2. Mix luciferase reporter cDNAs (1.2 µg) and b-galactosidase expression vector (0.8 µg) with the FuGENE
TM6 transfection
reagent (3 µl) in 100 µl of serum-free DMEM medium, and stand for 15 min at room temperature.
3. Add DNA-FuGENE
TM6 reagent mixture directly to the cells, and ensure even dispersal by swirling the wells of dishes.
4. Withdraw the medium after 24 h, and wash cells once with 1 ml of Ca
2+/ Mg
2+-free-DMEM.Mima et al. 88
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5. Add 200 µl of lysis buffer to the cells. Incubate for 15 min at room temperature. Scrape the lysed cells from the dish using a
rubber policeman. Transfer the cell lysate to a 1.5-ml microfuge tube.
6. Centrifuge the cell lysate at 18,500 x g for 2 min at 4 °C. Save the supernatant as cell extract.
7. Divide an aliquot, and store frozen at -80 °C until use. Usually, about 20 µg of protein (0.1 mg/ml, 200 µl) was obtained under
our conditions.
Assay of Luciferase Activity
Luciferase activity was measured using Promega’s luciferase assay system according to the manufacturer’s instruction. The
luciferase assay reagent contains the following in a final volume of 50 µl:
· 20 mM tricine, pH 7.8, 470 µM luciferin, 530 µM ATP, 270 µM Coenzyme A, 1.07 mM (MgCO3)4Mg(OH)2•5H2O, 2.67
mM MgSO4, 0.1 mM EDTA, and 33.3 mM dithiothreitol
1. Initiate the reaction by adding 10 µl of cell extract.
2. Measure the light output for a period of 20-40 s at room temperature in a luminometer.
Assay of b b b b-Galactosidase
b-Galactosidase activity is assayed using CPRG as substrate. The reaction mixture contains the following in a final volume of 250
µl:
· 0.1 M Na-phosphate buffer, pH 7.5, 10 mM KCl, 1 mM MgSO4, 50 mM b-mercaptoethanol, 2.5 mM CPRG, and cell
extract
1. Initiate the reaction by adding 2-5 µl of cell extract.
2. Incubate at 37 °C for 5 - 15 min.
3. Withdraw a 90-µl aliquot, and add 37.5 µl of 1 M Na2CO3
4. Measure the absorbance at 574 nm (A574) in a spectrophotometer.
Preparation of Nuclear Extract
The buffer contains the following:
· Buffer A: 10 mM Hepes, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 1 mM
phenylmethylsulfonyl fluoride, 10 µg/ml leupeptine, 10 µg/ml antipain, and 10 µg/ml pepstatin A
· Buffer B: 20 mM Hepes, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM
phenylmethylsulfonyl fluoride, 10 µg/ml leupeptine, 10 µg/ml antipain, and 10 µg/ml pepstatin A
1. Dissect the tissue quickly after decapitation. Wash the tissue with PBS. Pulverize it gently with a Teflon pestle in 4 volumes of
buffer A. Transfer to a centrifuge tube. The weight of tissues of one adult rat was as follows; forebrain, about 0.9 g; brainstem,
about 0.9 g; cerebellum, about 0.2 g; liver, about 5 g; kidney, about 3 g; spleen, about 0.8 g.
2. Incubate the homogenate for 15 min at 0 °C.
3. Add 40% Nonidet P-40 to a final concentration of 1%. Vortex the tube vigorously for 10 s.
4. Centrifuge the mixture at 5,000 rpm for 5 min.
5. Remove the supernatant, and resuspend the nuclear pellet in buffer B.
6. Incubate for 5 min at 4 °C with shaking.
7. Centrifuge at 15,000 rpm for 15 min at 4 °C. Save the supernatant as nuclear extract. Divide the fraction into aliquots and store
at -80 °C. Usually about 5-7 mg/ml protein was obtained under the above conditions.
Preparation of End-labeled Probe DNA
The buffer contains the following:
· STE solution: 0.1 M NaCl, 10 mM Tris/HCl, pH 8.0, and 1 mM EDTA
· Labeling buffer: 50 mM Tris/HCl, pH 8.0, 10 mM MgCl2, 10 mM 2-mercaptoethanol, 5 mM spermidine, and 1 mM
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The sequence of the oligonucleotide corresponding to bases -66 to -35 of the 5’-flanking region of the b CaM kinase II gene is as
follows:
   -66
5’-CAG CCA GCC CGG CCC CCG CCC GGC GCC GCG A-3’
3’-   TC GGT CGG GCC GGG GGC GGG CCG CGG CGC TC-5’
  -35
1. Mix the sense and antisense oligonucleotide probes (10 ng each) in 5 µl of STE solution (annealing buffer). Heat the mixture
at 90 °C for 3 min. Cool it gradually to room temperature for about 1 hr.
2. Add 20 µl of labeling buffer to the solution, including 10 units of T4 nucleotide kinase and [g-
32P]ATP (0.37 MBq).
3. Incubate at 37 °C for 60 min.
4. Heat at 70 °C for 5 min to terminate the reaction.
5. Add 75 µl of STE solution (total volume about 100 µl).
6. Apply to a spun column of Sephadex G-50 equilibrated with STE solution.
7. Centrifuge the column at 2000 rpm for 50 s.
8. Obtain the effluent (about 100 µl) as labeled probe. Usually about 2 - 3 x 10
6 cpm was incorporated into the probe under the
conditions.
Isolation of Labeled Probe by Spun-column
The spun-column procedure was adapted from a method described previously (20).
1. Plug the 1-ml disposable syringe with a small amount of sterile glass wool.
2. Prepare a column of Sephadex G-50 (0.9-ml bed volume) equilibrated with STE solution in the syringe.
3. Insert the column into a plastic centrifuge tube and centrifuge at 2000 rpm for 50 s. Since usually the Sephadex G-50 packs
down during centrifugation, Sephadex G-50 is added until the packed column volume is 0.9 ml.
4. Add 100 µl of STE to the column, and centrifuge at 2000 rpm for 50 s. Repeat this step once.
5. Apply the labeled DNA probe to the column in a total volume of 100 µl. Centrifuge at exactly the same speed and time as
before.
6. Collect about 100 µl of effluent from the syringe into a plastic tube.
7. Prepacked columns for the isolation of labeled probe are commercially available (such as MicroSpinTM S-300 HR column,
Amersham Pharmacia Biotec, etc).
Gel Mobility Shift Analysis
The solution contains the following:
· Binding buffer: 25 mM Tris/HCl, pH 7.5, 75 mM KCl, 1 mM EGTA, 1 µg poly (dI-dC), and 13% glycerol
· Polyacrylamide gel mixture: 6.4% polyacrylamide/bisacrylamide (29:1), 5% glycerol, and TBE
· Dye solution: 25% Ficol, 0.05% bromophenol blue, and 0.05% xylene cyanol
1. Preincubate nuclear extract (10 µg protein) in 20 µl of binding buffer for 20 min at 0 °C.
2. Initiate the reaction by adding 
32P-labeled probe DNA (20-50 fmol DNA, about 1 x 10
4 cpm).
3. Incubate at 0 °C for 30 min.
4. Add 2 µl of dye solution to the reaction mixture.
5. Withdraw a 15-µl aliquot and subject to 6.4% polyacrylamide gel electrophoresis with 0.5x TBE at 10 V/cm (25-30 mA) for
30 min.
6. Fix the gel in 10% acetic acid and 10% methanol solution for 10 min, and then wash the gel with distilled water.
7. Dry the gel at 70 °C for 2 hr.
8. Expose to X-ray film with an enhancing screen for 4 - 24 h at -80 °C.
9. Develop the film and detect the radioactive band. Alternatively, the radioactive bands can be analyzed in an imaging analyzer
BAS 1500 Mac (Fuji Film Co., Tokyo) according to the manufacturer’s instructions.